Loading...
XSHE000028
Market cap1.88bUSD
Jan 16, Last price  
26.38CNY
1D
-0.83%
1Q
-6.39%
Jan 2017
-48.74%
Name

China National Accord Medicines Corp Ltd

Chart & Performance

D1W1MN
XSHE:000028 chart
P/E
8.64
P/S
0.18
EPS
3.05
Div Yield, %
2.48%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
11.85%
Revenues
75.48b
+2.77%
1,576,085,2831,635,568,5175,667,611,8046,878,305,4838,360,350,19810,949,936,87113,064,428,14815,130,338,57118,011,759,17821,199,466,39923,954,331,02825,993,139,27741,248,429,32241,263,629,11843,122,385,52152,045,764,14359,649,455,01268,357,809,57173,443,136,98875,477,484,620
Net income
1.60b
+7.57%
27,254,14835,765,33172,555,229124,914,225154,807,067192,713,805261,116,656330,307,489475,792,491520,488,198652,497,176761,312,2611,186,601,8991,057,791,9301,210,742,4351,271,289,1831,401,892,5931,336,427,7521,486,707,6521,599,255,755
CFO
2.94b
+14.71%
130,295,006148,275,068181,729,86187,698,080246,580,438270,845,132428,159,420227,316,131323,955,332465,028,09901,047,979,1021,472,545,5871,285,291,9111,322,606,3522,000,352,0831,502,746,5981,655,180,9762,560,430,6122,937,138,679
Dividend
Jun 25, 20240.68 CNY/sh
Earnings
May 08, 2025

Profile

China National Accord Medicines Corporation Ltd. engages in the distribution of medicine and pharmaceutical products. The company sells Chinese traditional, bio-chemical, biological, and diagnosis medicines, as well as antibiotics; chemical preparations; food products; chemical products; and various commodities. It also engages in the sale of medical apparatus and instruments; provision of freight transportation, storage, loading and unloading, and professional consultation services; provision of glass wares, cosmetics, and daily merchandise, as well as goods agency services; import and export of technology; leasing of house properties; and wholesale and retail of health products. As of December 31, 2021, the company operated a network of 8,798 drugstores, including 7,257 directly owned stores and 1,541 franchised stores covering 20 provinces, autonomous regions, and municipalities in China. The company was founded in 2004 and is based in Shenzhen, China. China National Accord Medicines Corporation Ltd. is a subsidiary of Sinopharm Group Co., Ltd.
IPO date
Aug 09, 1993
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
75,477,485
2.77%
73,443,137
7.44%
Cost of revenue
69,303,509
69,996,501
Unusual Expense (Income)
NOPBT
6,173,976
3,446,636
NOPBT Margin
8.18%
4.69%
Operating Taxes
514,739
539,332
Tax Rate
8.34%
15.65%
NOPAT
5,659,237
2,907,303
Net income
1,599,256
7.57%
1,486,708
11.24%
Dividends
(342,502)
(256,876)
Dividend yield
2.12%
1.82%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
12,300,475
2,173,505
Long-term debt
2,903,575
2,672,308
Deferred revenue
80,108
Other long-term liabilities
803,243
561,964
Net debt
5,626,376
(4,092,529)
Cash flow
Cash from operating activities
2,937,139
2,560,431
CAPEX
(322,208)
Cash from investing activities
(135,435)
Cash from financing activities
FCF
(6,492,587)
3,278,151
Balance
Cash
6,502,348
6,016,350
Long term investments
3,075,327
2,921,993
Excess cash
5,803,801
5,266,185
Stockholders' equity
16,438,985
17,326,532
Invested Capital
29,729,545
17,910,070
ROIC
23.76%
16.39%
ROCE
17.38%
14.77%
EV
Common stock shares outstanding
556,565
556,565
Price
28.99
14.58%
25.30
-11.06%
Market cap
16,134,822
14.58%
14,081,097
-11.06%
EV
25,324,229
13,307,384
EBITDA
7,599,631
4,754,061
EV/EBITDA
3.33
2.80
Interest
285,043
261,908
Interest/NOPBT
4.62%
7.60%